Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Cyclophosphamide

4

I.a Pneumonitis (ILD), acute and/or severe (may cause ARDS)

2
Last update : 15/08/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Alkylating agents
5
Cyclophosphamide (i.v infusional)
2

Publications

Acute respiratory failure during first cyclophosphamide infusion in a patient with systemic lupus erythematosus.
Zeitschrift fur Rheumatologie 2014 Dec;73;939-41 2014 Dec
Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies.
Bone marrow transplantation 2000 Feb;25;309-13 2000 Feb
[Cyclophosphamide-induced interstitial pneumopathy. Course data of bronchoalveolar lavage apropos of a case and review of the literature].
Revue de pneumologie clinique 1999 Apr;55;100-4 1999 Apr
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
American journal of respiratory and critical care medicine 1996 Dec;154;1851-6 1996 Dec
Interstitial pneumonia after prolonged treatment with cyclophosphamide.
The American review of respiratory disease 1973 Jul;108;114-7 1973 Jul

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies